Due to strong demand for lithium-ion batteries and other important markets, Arkema’s previously announced 35% fluoropolymer capacity increase at its Changshu site in China is now revised upwards to a capacity increase of 50%.

This new production capacity will be part of Arkema’s previously announced major bio-factory currently under construction on Jurong Island in Singapore.

To support its customers’ strong growth, in particular in the sports and consumer goods markets, Arkema will invest at its Serquigny plant in France.